{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:14:31Z","timestamp":1781900071936,"version":"3.54.5"},"reference-count":51,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T00:00:00Z","timestamp":1561161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Idiopathic Pulmonary Arterial Hypertension (IPAH) is a deadly and disabling disease characterized by severe vascular remodeling of small pulmonary vessels by fibroblasts, myofibroblasts and vascular smooth muscle cell proliferation. Recent studies suggest that the Natriuretic Peptide Clearance Receptor (NPR-C) signaling pathways may play a crucial role in the development of IPAH. Reduced expression or function of NPR-C signaling in pulmonary artery smooth muscle cells may contribute to the pulmonary vascular remodeling, which is characteristic of this disease. The likely mechanisms may involve an impaired interaction between NPR-C, specific growth factors and other signal transduction pathways including but not limited to Gq\u03b1\/mitogen-activated protein kinase (MAPK)\/PI3K and AKT signaling. The resulting failure of growth suppression in pulmonary artery smooth muscle cells provides critical clues to the cellular pathobiology of IPAH. The reciprocal regulation of NPR-C signaling in models of tissue remodeling may thus provide new insights to our understanding of IPAH.<\/jats:p>","DOI":"10.3390\/ijms20123063","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T02:37:40Z","timestamp":1561343860000},"page":"3063","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pulmonary Arterial Hypertension Due to NPR-C Mutation: A Novel Paradigm for Normal and Pathologic Remodeling?"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7142-5477","authenticated-orcid":false,"given":"Emmanuel Eroume-A","family":"Egom","sequence":"first","affiliation":[{"name":"St Martha\u2019s Regional Hospital, Dalhousie University, Antigonish, B2G 2G7 NS, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,22]]},"reference":[{"key":"ref_1","first-page":"112","article-title":"New insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease","volume":"9","author":"Egom","year":"2017","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Humbert, M., Guignabert, C., Bonnet, S., Dorfmuller, P., Klinger, J.R., Nicolls, M.R., Olschewski, A.J., Pullamsetti, S.S., Schermuly, R.T., and Stenmark, K.R. (2019). Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur. Respir. J., 53.","DOI":"10.1183\/13993003.01887-2018"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Simonneau, G., Montani, D., Celermajer, D.S., Denton, C.P., Gatzoulis, M.A., Krowka, M., Williams, P.G., and Souza, R. (2019). Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Respir. J., 53.","DOI":"10.1183\/13993003.01913-2018"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1183\/09031936.00092306","article-title":"An epidemiological study of pulmonary arterial hypertension","volume":"30","author":"Peacock","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jacc.2004.02.033","article-title":"Pathologic assessment of vasculopathies in pulmonary hypertension","volume":"43","author":"Pietra","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cardfail.2013.08.004","article-title":"Right ventricular afterload and the role of nitric oxide metabolism in left-sided heart failure","volume":"19","author":"Dupont","year":"2013","journal-title":"J. Card. Fail."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijcard.2018.06.001","article-title":"Evolving use of natriuretic peptide receptor type-C as part of strategies for the treatment of pulmonary hypertension due to left ventricle heart failure","volume":"281","author":"Egom","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0735-1097(17)35291-9","article-title":"New Insights and New Hope for Pulmonary Arterial Hypertension: Natriuretic Peptides Clearance Receptor as a Novel Therapeutic Target for a Complex Disease","volume":"69","author":"Egom","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/01.CIR.0000141802.29945.34","article-title":"Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia\/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide","volume":"110","author":"Hobbs","year":"2004","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12265-015-9619-3","article-title":"BNP and Heart Failure: Preclinical and Clinical Trial Data","volume":"8","author":"Egom","year":"2015","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1139\/cjpp-2014-0356","article-title":"Mechanisms of renal hyporesponsiveness to BNP in heart failure","volume":"93","author":"Egom","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.peptides.2004.09.023","article-title":"Natriuretic peptide receptor-C signaling and regulation","volume":"26","year":"2005","journal-title":"Peptides"},{"key":"ref_17","unstructured":"Choi, S. (2017). Natriuretic Peptide Receptor Type C (NPRC). Encyclopedia of Signaling Molecules, Ed. Springer New York."},{"key":"ref_18","first-page":"3","article-title":"Clinical aspects of c-type natriuretic peptide on the cardiovascular system","volume":"1","author":"Donoso","year":"2015","journal-title":"Int. J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardiores.2006.08.012","article-title":"Intracellular peptides of natriuretic peptide receptor-C inhibit vascular hypertrophy via Gq\u03b1\/MAP kinase signaling pathways","volume":"72","author":"Li","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Jain, A., and Anand-Srivastava, M.B. (2018). Natriuretic peptide receptor-C-mediated attenuation of vascular smooth muscle cell hypertrophy involves Gqalpha\/PLCbeta1 proteins and ROS-associated signaling. Pharmacol. Res. Perspect., 6.","DOI":"10.1002\/prp2.375"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2119\/molmed.2014.00166","article-title":"Blockade of Multidrug Resistance-Associated Proteins Aggravates Acute Pancreatitis and Blunts Atrial Natriuretic Factor\u2019s Beneficial Effect in Rats: Role of MRP4 (ABCC4)","volume":"21","author":"Ventimiglia","year":"2015","journal-title":"Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1152\/physiolgenomics.00083.2018","article-title":"Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function","volume":"50","author":"Pandey","year":"2018","journal-title":"Physiol. Genom."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Moyes, A.J., and Hobbs, A.J. (2019). C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092281"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"H1970","DOI":"10.1152\/ajpheart.00893.2003","article-title":"Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor","volume":"286","author":"Rose","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1124\/mol.65.4.917","article-title":"Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells","volume":"65","author":"Mouawad","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1139\/y11-054","article-title":"Guanylyl cyclase \/ atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation","volume":"89","author":"Pandey","year":"2011","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00109-010-0641-2","article-title":"NPR-C: a component of the natriuretic peptide family with implications in human diseases","volume":"88","author":"Rubattu","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1113\/jphysiol.2007.144253","article-title":"Natriuretic peptide C receptor signalling in the heart and vasculature","volume":"586","author":"Rose","year":"2008","journal-title":"J. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.201712-2553OC","article-title":"FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension","volume":"199","author":"Tian","year":"2019","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.peptides.2004.08.030","article-title":"Atrial natriuretic peptide in hypoxia","volume":"26","author":"Chen","year":"2005","journal-title":"Peptides"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"L155","DOI":"10.1152\/ajplung.2001.281.1.L155","article-title":"Tyrosine kinase receptor activation inhibits NPR-C in lung arterial smooth muscle cells","volume":"281","author":"Sun","year":"2001","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/FJC.0000000000000192","article-title":"Role of the sympathetic autonomic nervous system in hypoxic remodeling of the fetal cerebral vasculature","volume":"65","author":"Adeoye","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"L981","DOI":"10.1152\/ajplung.2000.278.5.L981","article-title":"Vascular remodeling and ET-1 expression in rat strains with different responses to chronic hypoxia","volume":"278","author":"Aguirre","year":"2000","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1165\/ajrcmb.22.3.3701","article-title":"Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension","volume":"22","author":"Chassagne","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_35","first-page":"22","article-title":"Expression of FGF-b and c-myc in rats lung tissue affected by hypoxia","volume":"20","author":"Ouyang","year":"1997","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00441-009-0841-7","article-title":"Extracellular matrix genes as hypoxia-inducible targets","volume":"339","author":"Myllyharju","year":"2010","journal-title":"Cell Tissue Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/mcne.1999.0827","article-title":"PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways","volume":"15","author":"Baron","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"725102","DOI":"10.1155\/2013\/725102","article-title":"Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases","volume":"2013","author":"Bonacina","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","article-title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","volume":"478","author":"Ehret","year":"2011","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"33662","DOI":"10.18632\/oncotarget.9358","article-title":"NPR-C gene polymorphism is associated with increased susceptibility to coronary artery disease in Chinese Han population: a multicenter study","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/ALN.0b013e31819c7496","article-title":"Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting","volume":"110","author":"Fox","year":"2009","journal-title":"Anesthesiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"El Andalousi, J., Li, Y., and Anand-Srivastava, M.B. (2013). Natriuretic peptide receptor-C agonist attenuates the expression of cell cycle proteins and proliferation of vascular smooth muscle cells from spontaneously hypertensive rats: role of Gi proteins and MAPkinase\/PI3kinase signaling. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076183"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1113\/expphysiol.2005.030080","article-title":"Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II","volume":"90","author":"Touyz","year":"2005","journal-title":"Exp. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"H3144","DOI":"10.1152\/ajpheart.00327.2006","article-title":"Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gi\u03b1 protein\/MAP kinase\/PI3-kinase\/AKT pathways","volume":"291","author":"Hashim","year":"2006","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/jcp.20793","article-title":"BNP-induced activation of cGMP in human cardiac fibroblasts: Interactions with fibronectin and natriuretic peptide receptors","volume":"209","author":"Huntley","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/HYPERTENSIONAHA.110.160796","article-title":"The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic peptide","volume":"57","author":"Sangaralingham","year":"2011","journal-title":"Hypertension"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1113\/jphysiol.2014.283135","article-title":"Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C","volume":"593","author":"Egom","year":"2015","journal-title":"J. Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e006863","DOI":"10.1161\/CIRCEP.118.006863","article-title":"NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice","volume":"12","author":"Jansen","year":"2019","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jacbts.2018.08.004","article-title":"Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice","volume":"3","author":"Mackasey","year":"2018","journal-title":"Jacc. Basic Transl. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Rahali, S., Li, Y., and Anand-Srivastava, M.B. (2018). Contribution of oxidative stress and growth factor receptor transactivation in natriuretic peptide receptor C-mediated attenuation of hyperproliferation of vascular smooth muscle cells from SHR. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191743"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.118.036344","article-title":"Endothelial C-Type Natriuretic Peptide Is a Critical Regulator of Angiogenesis and Vascular Remodeling","volume":"139","author":"Bubb","year":"2019","journal-title":"Circulation"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/12\/3063\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:00:39Z","timestamp":1760187639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/12\/3063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,22]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,6]]}},"alternative-id":["ijms20123063"],"URL":"https:\/\/doi.org\/10.3390\/ijms20123063","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,22]]}}}